Nicola Gianotti

3.2k total citations
153 papers, 1.5k citations indexed

About

Nicola Gianotti is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Nicola Gianotti has authored 153 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 129 papers in Infectious Diseases, 116 papers in Virology and 30 papers in Emergency Medicine. Recurrent topics in Nicola Gianotti's work include HIV/AIDS drug development and treatment (120 papers), HIV Research and Treatment (112 papers) and HIV/AIDS Research and Interventions (71 papers). Nicola Gianotti is often cited by papers focused on HIV/AIDS drug development and treatment (120 papers), HIV Research and Treatment (112 papers) and HIV/AIDS Research and Interventions (71 papers). Nicola Gianotti collaborates with scholars based in Italy, United States and United Kingdom. Nicola Gianotti's co-authors include Adriano Lazzarin, Antonella Castagna, Laura Galli, Vincenzo Spagnuolo, Enzo Boeri, Massimo Clementi, Stefania Salpietro, Silvia Nozza, Hamid Hasson and Andrea Galli and has published in prestigious journals such as PLoS ONE, Cancer and Clinical Infectious Diseases.

In The Last Decade

Nicola Gianotti

146 papers receiving 1.5k citations

Peers

Nicola Gianotti

VIROL

EPIDE

Clare Brennan United States

Michael Wohlfeiler United States

Benoît Trottier Canada

J Aboulker France

Hans-Jürgen Stellbrink Germany

Sidonie Lambert-Niclot France

Gary Richmond United States

Suteeraporn Pinyakorn Thailand

Chris Tsoukas Canada

Peter Gute Germany

Clare Brennan United States

Nicola Gianotti

1.3k ×1.1

1.0k ×0.9

VIROL

299 ×1.0

EPIDE

346 ×1.1

179 ×1.3

Citations per year, relative to Nicola Gianotti Nicola Gianotti (= 1×) peers Clare Brennan

Countries citing papers authored by Nicola Gianotti

Since Specialization

Citations

This map shows the geographic impact of Nicola Gianotti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Gianotti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Gianotti more than expected).

Fields of papers citing papers by Nicola Gianotti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Gianotti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Gianotti. The network helps show where Nicola Gianotti may publish in the future.

Co-authorship network of co-authors of Nicola Gianotti

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Gianotti. A scholar is included among the top collaborators of Nicola Gianotti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Gianotti. Nicola Gianotti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vergori, Alessandra, Nicola Gianotti, Alessandro Tavelli, et al.. (2024). Probability of Starting Two-Drug Regimen (2DR) vs. Three-Drug Regimen (3DR) in ART-Naïve and ART-Experienced Person with HIV (PWH) Across the First Wave of COVID-19 Pandemic. Viruses. 16(12). 1822–1822.

Raccagni, Angelo Roberto, Nicola Gianotti, Matteo Moro, et al.. (2023). Mpox Virus: Control of In-Hospital Occupational Transmission Experience from a Tertiary Level Hospital in Milan, Italy. Life. 13(8). 1705–1705. 3 indexed citations

Canetti, Diana, Laura Galli, Silvia Nozza, et al.. (2023). Bictegravir/Emtricitabine/Tenofovir Alafenamide Treatment: Efficacy and Tolerability in Clinical Practice. Drug Design Development and Therapy. Volume 17. 3697–3706. 2 indexed citations

Saladini, Francesco, Franco Maggiolo, Sergio Ferrara, et al.. (2023). Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry. International Journal of Antimicrobial Agents. 61(3). 106737–106737. 4 indexed citations

Candela, Caterina, Angelo Roberto Raccagni, Elena Bruzzesi, et al.. (2023). Human Monkeypox Experience in a Tertiary Level Hospital in Milan, Italy, between May and October 2022: Epidemiological Features and Clinical Characteristics. Viruses. 15(3). 667–667. 16 indexed citations

Candela, Caterina, Laura Galli, Alberto Rizzo, et al.. (2023). Mpox DNA clearance in semen over 6‐month follow‐up. Journal of Medical Virology. 95(12). e29259–e29259. 4 indexed citations

Fabeni, Lavinia, Maria Mercedes Santoro, Patrizia Lorenzini, et al.. (2020). Evaluation of HIV Transmission Clusters among Natives and Foreigners Living in Italy. Viruses. 12(8). 791–791. 6 indexed citations

Galli, Laura, et al.. (2018). Glomerular filtration rate estimated by cystatin C formulas in HIV-1 patients treated with dolutegravir, rilpivirine or cobicistat.. PubMed. 41(4). 256–261. 9 indexed citations

Gianotti, Nicola, Laura Galli, Marco Ripa, et al.. (2018). Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen. International Journal of Antimicrobial Agents. 52(4). 492–499. 10 indexed citations

10.

Madeddu, Giordano, Stefano Rusconi, Alessandro Cozzi‐Lepri, et al.. (2017). Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50 cp/mL. Infection. 45(4). 521–528. 9 indexed citations

11.

Gianotti, Nicola, Andrea Poli, Silvia Nozza, et al.. (2015). Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single‐tablet regimen in virologically suppressed HIV‐positive patients on stable antiretroviral therapy. Journal of the International AIDS Society. 18(1). 20037–20037. 9 indexed citations

12.

Gianotti, Nicola, Laura Galli, Stefania Salpietro, et al.. (2013). Virological rebound in human immunodeficiency virus-infected patients with or without residual viraemia: results from an extended follow-up. Clinical Microbiology and Infection. 19(12). E542–E544. 16 indexed citations

13.

Gianotti, Nicola, Laura Galli, Maurizio Zazzi, et al.. (2011). No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy. Journal of Medical Virology. 83(3). 391–398. 1 indexed citations

14.

Nozza, Silvia, Laura Galli, Alessandro Soria, et al.. (2010). Raltegravir, maraviroc, etravirine: an effective protease inhibitor and nucleoside reverse transcriptase inhibitor-sparing regimen for salvage therapy in HIV-infected patients with triple-class experience. AIDS. 24(6). 924–928. 37 indexed citations

15.

Canducci, Filippo, Beatrice Barda, Elisa Rita Ceresola, et al.. (2010). Evolution patterns of raltegravir-resistant mutations after integrase inhibitor interruption. Clinical Microbiology and Infection. 17(6). 928–934. 22 indexed citations

16.

Spagnuolo, Vincenzo, Nicola Gianotti, Elena Seminari, et al.. (2009). Changes in Darunavir/r Resistance Score After Previous Failure to Tipranavir/r in HIV-1-Infected Multidrug-Resistant Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 50(2). 192–195. 8 indexed citations

17.

Gianotti, Nicola, Elena Seminari, Adriano Lazzarin, et al.. (2005). Redistribution of Human Immunodeficiency Virus Type 1 Variants Resistant to Protease Inhibitors after a Protease Inhibitor-Sparing Regimen. AIDS Research and Human Retroviruses. 21(6). 545–554. 2 indexed citations

18.

Turriziani, Ombretta, et al.. (2004). Lack of Reduction of Thymidine Kinase Activity in Stavudine-Treated HIV-Infected Patients. AIDS Research and Human Retroviruses. 20(7). 701–703. 2 indexed citations

19.

Boeri, Enzo, Nicola Gianotti, Filippo Canducci, et al.. (2003). Evolutionary Characteristics of HIV Type 1 Variants Resistant to Protease Inhibitors in the Absence of Drug-Selective Pressure. AIDS Research and Human Retroviruses. 19(12). 1151–1153. 16 indexed citations

20.

Fortis, Claudio, Laura Soldini, Silvia Ghezzi, et al.. (2002). Tumor Necrosis Factor α , Interleukin 2, and Soluble Interleukin 2 Receptor Levels in Human Immunodeficiency Virus Type 1-Infected Individuals Receiving Intermittent Cycles of Interleukin 2. AIDS Research and Human Retroviruses. 18(7). 491–499. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact